]>
IRCT20171220037976N1 IRCT 2018-04-21 Shiraz University of Medical Sciences The study of the effect of Thyme oxymel on over weight Comparison of the efficacy of Thymoxymel with 10% thyme and Thymoxymel with 1.5 g thyme and 3 g thyme on weight loss in overweight people 2018-06-22 anticipated 108 Complete https://irct.ir/trial/28583 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: 108 people who have been admitted to the study, who had been previously visited by the doctor, are divided into three groups of 36 members by randomly assigned random numbers.Blocked randomization is intended to ensure that exactly the same number of participants participates in consecutive but equal intervals, into three groups.The size of each block in this study is 36 We assign a number between 1 and 6 to each of the three permutations then we generate 36 random numbers in range 1 through 6 by RANDBETWEEN in Excel, Blinding description: To the first group, a normal oxymel with thyme flavor twice everyday 10 cc (as a placebo)To the second group, oxymel with 1.5 grams of thyme , twice everyday 10 cc,To the third group, oxymel with 3 grams of thyme , twice everyday 10 cc,The medication should be given to all three groups for a period of three months at monthly intervals.The shape and taste of all three types of medication are the same.During the study, all people, including doctors, patients, and the person in charge of delivery of the drug, will not be aware of the drug used. 3 obesity - over weight. Intervention 1: Control group: oxymel with thyme flavore 10 cc twice daily. Intervention 2: Intervention group1: thyme oxymel with 1.5 gram thyme in 10 cc twice daily. Intervention 3: Intervention group2: thyme oxymel with 3 gram thyme in 10 cc twice daily. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is the information of the individuals participating in the private plan And at the beginning of the plan, we have given the participants a commitment not to publish private information So we can not post this information
public Jafar Abolghasemy Nezhad Shirazi
Shiraz Medical School, Imam Hossein Square, Shiraz
Shiraz Iran (Islamic Republic of) 713485794 +98 71 3639 5768 jafar20200@yahoo.com Shiraz University of Medical Sciences scientific Majid Nimruzi
School of Medicine, Zand Avenue, next to the Governor's Office,shiraz
Shiraz Iran (Islamic Republic of) 713485794 +98 71 3230 5645 mnimruzi@yahoo.com Shiraz University of Medical Sciences Iran (Islamic Republic of) Body mass index (BMI) above 25 kg / m Conscious Consent to Participate in the Study Waist to hip ratio index (WHR) in men1 and women 0.9 Not taking any medications in the past month 20 years 60 years Both pregnancy lactation alcohol use diabetes melitus thymus allergy reaction history acute or chronic liver disease cancer hypo or hyper thyroidism renal failuer Gastroesophageal reflux Unwillingness of the patient to continue participating in the plan for any reason E66.9 Obesity, unspecified Placebo Treatment - Drugs Treatment - Drugs Control group: oxymel with thyme flavore 10 cc twice daily Intervention group1: thyme oxymel with 1.5 gram thyme in 10 cc twice daily Intervention group2: thyme oxymel with 3 gram thyme in 10 cc twice daily Body Mass Index. Timepoint: monthly. Method of measurement: From the division of weight into squared height. Lipid profile study. Timepoint: At the start and end of study. Method of measurement: blood sampling. Liver enzyme study. Timepoint: At the start and end of study. Method of measurement: blood sampling. Abdominal to hip circumference ratio study. Timepoint: monthly. Method of measurement: by meter. Weight. Timepoint: monthly. Method of measurement: scale. Shiraz University of Medical Sciences Approved 2017-11-06 Ethics committee of Shiraz University of Medical Sciences medical School, Zand Street,Imam Hossein Square,Shiraz Shiraz Fars Iran (Islamic Republic of)